Sotera Health Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US83601L1026
USD
13.57
0.16 (1.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
303.44
311.31
294.34
254.52
290.20
285.47
276.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
303.44
311.31
294.34
254.52
290.20
285.47
276.59
Raw Material Cost
140.54
136.84
137.02
134.42
141.22
142.95
139.22
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
33.47
39.94
40.74
40.28
66.15
36.91
31.84
Selling and Distribution Expenses
48.31
49.04
52.43
48.69
47.03
51.42
52.16
Other Expenses
-3.35
-3.99
-4.07
-4.03
-6.62
-3.69
-3.18
Total Expenditure (Excl Depreciation)
188.86
185.88
189.45
183.10
188.25
194.37
191.38
Operating Profit (PBDIT) excl Other Income
114.60000000000001
125.39999999999999
104.9
71.39999999999999
102
91.1
85.19999999999999
Other Income
-1.47
4.86
0.54
-1.80
26.07
1.27
-5.68
Operating Profit (PBDIT)
146.15
159.17
141.01
110.99
167.73
135.56
120.00
Interest
33.47
39.94
40.74
40.28
66.15
36.91
31.84
Exceptional Items
-9.15
-17.41
-45.80
-44.15
-16.91
-12.71
-32.55
Gross Profit (PBDT)
162.90
174.47
157.32
120.11
148.98
142.52
137.37
Depreciation
33.04
28.89
35.58
41.38
39.71
43.19
40.47
Profit Before Tax
70.50
72.94
18.90
-14.82
44.96
42.75
15.14
Tax
35.65
24.54
10.94
-1.56
32.64
25.76
6.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
34.85
48.40
7.96
-13.26
12.32
16.99
8.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
34.85
48.40
7.96
-13.26
12.32
16.99
8.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
34.85
48.40
7.96
-13.26
12.32
16.99
8.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
606.03
550.47
511.28
414.09
404.91
470.16
422.76
Earnings per share (EPS)
0.12
0.17
0.03
-0.05
0.04
0.06
0.03
Diluted Earnings per share
0.12
0.17
0.03
-0.05
0.04
0.06
0.03
Operating Profit Margin (Excl OI)
37.76%
40.29%
35.64%
28.06%
35.13%
31.91%
30.81%
Gross Profit Margin
34.12%
32.71%
18.51%
10.43%
29.18%
30.11%
20.1%
PAT Margin
11.48%
15.55%
2.7%
-5.21%
4.24%
5.95%
3.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is -2.54% vs 5.78% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -28.10% vs 505.00% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -4.34% vs 9.82% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -16.04% vs -1.97% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Sotera Health Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
303.44
338.97
-35.53
-10.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
303.44
338.97
-35.53
-10.48%
Raw Material Cost
140.54
147.56
-7.02
-4.76%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
33.47
8.12
25.35
312.19%
Selling and Distribution Expenses
48.31
107.56
-59.25
-55.09%
Other Expenses
-3.35
0.62
-3.97
-640.32%
Total Expenditure (Excl Depreciation)
188.86
269.41
-80.55
-29.90%
Operating Profit (PBDIT) excl Other Income
114.59
69.56
45.03
64.74%
Other Income
-1.47
0.00
-1.47
Operating Profit (PBDIT)
146.15
96.95
49.20
50.75%
Interest
33.47
8.12
25.35
312.19%
Exceptional Items
-9.15
-1.46
-7.69
-526.71%
Gross Profit (PBDT)
162.90
191.41
-28.51
-14.89%
Depreciation
33.04
27.39
5.65
20.63%
Profit Before Tax
70.50
59.98
10.52
17.54%
Tax
35.65
15.23
20.42
134.08%
Provisions and contingencies
0
0
0.00
Profit After Tax
34.85
44.74
-9.89
-22.11%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
34.85
44.74
-9.89
-22.11%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
34.85
44.74
-9.89
-22.11%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
606.03
911.45
-305.42
-33.51%
Earnings per share (EPS)
0.12
0.95
-0.83
-87.37%
Diluted Earnings per share
0.12
0.95
-0.83
-87.37%
Operating Profit Margin (Excl OI)
37.76%
20.52%
0.00
17.24%
Gross Profit Margin
34.12%
25.77%
0.00
8.35%
PAT Margin
11.48%
13.20%
0.00
-1.72%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 30.34 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -2.54% vs 5.78% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 4.55% vs -6.45% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.48 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -28.10% vs 505.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 182.93% vs -68.05% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.76 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -4.34% vs 9.82% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 4.16% vs -14.69% in Dec 2024

Quarterly - Interest
Interest 3.35 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -16.04% vs -1.97% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -49.40% vs 151.71% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.76%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024